Identification of 14-3-3β in human gastric cancer cells and its potency as a diagnostic and prognostic biomarker

Proteomics

Volumn 11, Issue 12, 2011, Pages 2423-2439

  Tseng, Chien Wei ^a   Yang, Jyh Chin ^b   Chen, Chiung Nien ^a,b,c   Huang, Hsuan Cheng ^d   Chuang, Kai Neng ^a   Lin, Chen Ching ^a,d   Lai, Hong Shiee ^b   Lee, Po Huang ^b   Chang, King Jen ^a,b,e   Juan, Hsueh Fen ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c RESEARCH CENTER FOR APPLIED SCIENCES   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e CHENG CHING GENERAL HOSPITAL   (Taiwan)

Author keywords

14 3 3 ; Biomarker; Biomedicine; Gastric cancer; Network analysis

Indexed keywords

BIOLOGICAL MARKER; FLUOROURACIL; PROTEIN 14 3 3; PROTEIN 14 3 3BETA; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CELL MIGRATION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STOMACH CANCER; SURVIVAL RATE; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

14-3-3 PROTEINS; ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EARLY DIAGNOSIS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; FLUOROURACIL; GENE EXPRESSION PROFILING; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PLASMIDS; PROGNOSIS; PROTEIN INTERACTION MAPPING; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STOMACH; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL;

EID: 79958088941     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201000449     Document Type: Article

References (35)

1. Parkin, D. M., Bray, F., Ferlay, J., Pisani, P., Global cancer statistics, 2002. CA Cancer J. Clin. 2005, 55, 74-108.
2. Macdonald, J. S., Gastric cancer - new therapeutic options. N. Engl. J. Med. 2006, 355, 76-77.
3. Yamazaki, H., Oshima, A., Murakami, R., Endoh, S., Ubukata, T., A long-term follow-up study of patients with gastric cancer detected by mass screening. Cancer 1989, 63, 613-617.
4. Kodama, I., Koufuji, K., Kawabata, S., Tetsu, S. et al., The clinical efficacy of CA 72-4 as serum marker for gastric cancer in comparison with CA19-9 and CEA. Int. Surg. 1995, 80, 45-48.
5. Ohuchi, N., Takahashi, K., Matoba, N., Sato, T. et al., Comparison of serum assays for TAG-72, CA19-9 and CEA in gastrointestinal carcinoma patients. Jpn. J. Clin. Oncol. 1989, 19, 242-248.
6. Hao, Y., Yu, Y., Wang, L., Yan, M. et al., IPO-38 is identified as a novel serum biomarker of gastric cancer based on clinical proteomics technology. J. Proteome Res. 2008, 7, 3668-3677.
7. Ychou, M., Duffour, J., Kramar, A., Gourgou, S., Grenier, J., Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer. Dis. Markers 2000, 16, 105-110.
8. Cho, W. C., Contribution of oncoproteomics to cancer biomarker discovery. Mol. Cancer 2007, 6, 25-37.
9. Frank, R., Hargreaves, R., Clinical biomarkers in drug discovery and development. Nat. Rev. Drug Discov. 2003, 2, 566-580.
10. MacKeigan, J. P., Clements, C. M., Lich, J. D., Pope, R. M. et al., Proteomic profiling drug-induced apoptosis in non-small cell lung carcinoma: identification of RS/DJ-1 and RhoGDIalpha. Cancer Res. 2003, 63, 6928-6934.
11. Qi, W., Liu, X., Qiao, D., Martinez, J. D., Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues. Int. J. Cancer 2005, 113, 359-363.
12. Cochran, D. A., Evans, C. A., Blinco, D., Burthem, J. et al., Proteomic analysis of chronic lymphocytic leukemia subtypes with mutated or unmutated Ig V(H) genes. Mol. Cell. Proteomics 2003, 2, 1331-1341.
13. Takihara, Y., Matsuda, Y., Hara, J., Role of the beta isoform of 14-3-3 proteins in cellular proliferation and oncogenic transformation. Carcinogenesis 2000, 21, 2073-2077.
14. Han, D. C., Rodriguez, L. G., Guan, J. L., Identification of a novel interaction between integrin beta1 and 14-3-3beta. Oncogene 2001, 20, 346-357.
15. Komiya, Y., Kurabe, N., Katagiri, K., Ogawa, M. et al., A novel binding factor of 14-3-3beta functions as a transcriptional repressor and promotes anchorage-independent growth, tumorigenicity, and metastasis. J. Biol. Chem. 2008, 283, 18753-18764.
16. Chan, C. H., Ko, C. C., Chang, J. G., Chen, S. F. et al., Subcellular and functional proteomic analysis of the cellular responses induced by Helicobacter pylori. Mol. Cell. Proteomics 2006, 5, 702-713.
17. Juan, H. F., Wang, I. H., Huang, T. C., Li, J. J. et al., Proteomics analysis of a novel compound: cyclic RGD in breast carcinoma cell line MCF-7. Proteomics 2006, 6, 2991-3000.
18. Lin, L. L., Chen, C. N., Lin, W. C., Lee, P. H. et al., Annexin A4: a novel molecular marker for gastric cancer with Helicobacter pylori infection using proteomics approach. Proteomics Clin. Appl. 2008, 2, 619-634.
19. Lauren, P., The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol. Microbiol. Scand. 1965, 64, 31-49.
20. Sobin L. H, Gospodarowicz, M. K., Wittekind, C. (Eds.), TNM Classification of Malignant Tumors, 5th Edn, John Wiley and Sons, Inc., New York 1997.
21. Xiao, T., Ying, W., Li, L., Hu, Z. et al., An approach to studying lung cancer-related proteins in human blood. Mol. Cell. Proteomics 2005, 4, 1480-1486.
22. Chen, G., Gharib, T. G., Wang, H., Huang, C. C. et al., Protein profiles associated with survival in lung adenocarcinoma. Proc. Natl. Acad. Sci. USA 2003, 100, 13537-13542.
23. Katayama, M., Sanzen, N., Funakoshi, A., Sekiguchi, K., Laminin gamma2-chain fragment in the circulation: a prognostic indicator of epithelial tumor invasion. Cancer Res. 2003, 63, 222-229.
24. Chang, C. C., Shih, J. Y., Jeng, Y. M., Su, J. L. et al., Connective tissue growth factor and its role in lung adenocarcinoma invasion and metastasis. J. Natl. Cancer Inst. 2004, 96, 364-375.
25. Mathivanan, S., Periaswamy, B., Gandhi, T. K., Kandasamy, K. et al., An evaluation of human protein-protein interaction data in the public domain. BMC Bioinformatics 2006, 7, S19.
26. Maere, S., Heymans, K., Kuiper, M., BiNGO: a cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 2005, 21, 3448-3449.
27. Shannon, P., Markiel, A., Ozier, O., Baliga, N. S. et al., Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13, 2498-2504.
28. Porter, G. W., Khuri, F. R., Fu, H., Dynamic 14-3-3/client protein interactions integrate survival and apoptotic pathways. Semin. Cancer Biol. 2006, 16, 193-202.
29. Hippo, Y., Taniguchi, H., Tsutsumi, S., Machida, N. et al., Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res. 2002, 62, 233-240.
30. Jaattela, M., Escaping cell death: survival proteins in cancer. Exp. Cell Res. 1999, 248, 30-43.
31. Yi, X., Luk, J. M., Lee, N. P., Peng, J. et al., Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence. Mol. Cell. Proteomics 2008, 7, 315-325.
32. Wadhwa, R., Takano, S., Kaur, K., Deocaris, C. C. et al., Upregulation of mortalin/mthsp70/Grp75 contributes to human carcinogenesis. Int. J. Cancer 2006, 118, 2973-2980.
33. Chung, Y. M., Yoo, Y. D., Park, J. K., Kim, Y. T., Kim, H. J., Increased expression of peroxiredoxin II confers resistance to cisplatin. Anticancer Res. 2001, 21, 1129-1133.
34. Xia, H. H., Yang, Y., Chu, K. M., Gu, Q. et al., Serum macrophage migration-inhibitory factor as a diagnostic and prognostic biomarker for gastric cancer. Cancer 2009, 115, 5441-5449.
35. Lim, J. W., Kim, H., Kim, J. M., Kim, J. S. et al., Cellular stress-related protein expression in Helicobacter pylori-infected gastric epithelial AGS cells. Int. J. Biochem. Cell Biol. 2004, 36, 1624-1634.